cardinal health glp-1 receptor agonist weight management diabetes treatments Clinical of Regain and Cardiometabolic Consequences After Discontinuation of GLP‐1 Agonists - Shah - 2026 - Diabetes, Obesity and Metabolism GLP-1 Agonists: Revolutionizing the Treatment

We completed a randomized, double-blind, placebo-controlled, proof-of-concept study to evaluate the safety and efficacy of oral NG101 as a potential therapy to reduce nausea and vomiting associated with the use of GLP-1 agonists

Llorens Castell P, Juan-Garca A, Corts JCM et al (2022) Application of an in vitro digestion model for wheat and red beetroot bread to assess the bioaccessibility of aflatoxin B1, Ochratoxin A and Zearalenone and betalains

Archives of OtolaryngologyHead & Neck Surgery, 120 (5), 547-551

Ensuring adequate protein intake is necessary when it comes to recovery and tissue repair (1.6 grams per kilogram of body weight daily for active individuals)